Scholar Home

 Follow this author

No co-authors
Citation indices
 AllSince 2009
Citations to my articles
Citations to my articles
Show: 1-20Next >
Title / AuthorCited by Year
Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis
TP Dalton, L He, B Wang, ML Miller, L Jin, KF Stringer, X Chang, ...
Proceedings of the National Academy of Sciences of the United States of ...
ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties
L He, K Girijashanker, TP Dalton, J Reed, H Li, M Soleimani, DW Nebert
Molecular pharmacology 70 (1), 171-180
Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter
K Girijashanker, L He, M Soleimani, JM Reed, H Li, Z Liu, B Wang, ...
Molecular pharmacology 73 (5), 1413-1423
Analysis and update of the human solute carrier (SLC) gene superfamily
L He, K Vasiliou, DW Nebert
Human genomics 3 (2), 195
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA proficient triple negative breast cancer to PARP inhibition
YH Ibrahim, C García-García, V Serra, L He, K Torres-Lockhart, A Prat, ...
Cancer Discovery
Cd 2+ versus Zn 2+ uptake by the ZIP8-dependent symporter: kinetics, electrogenicity and trafficking
Z Liu, H Li, M Soleimani, K Girijashanker, JM Reed, L He, TP Dalton, ...
Biochemical and biophysical research communications 365 (4), 814-820
Discovery of ZIP transporters that participate in cadmium damage to testis and kidney
L He, B Wang, EB Hay, DW Nebert
Toxicology and applied pharmacology 238 (3), 250-257
Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line
B Wang, SN Schneider, N Dragin, K Girijashanker, TP Dalton, L He, ...
American Journal of Physiology-Cell Physiology 292 (4), C1523-C1535
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma
MR Ramsey, L He, N Forster, B Ory, LW Ellisen
Cancer research 71 (13), 4373-4379
BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma
N Ibrahim, L He, CO Leong, D Xing, BY Karlan, EM Swisher, BR Rueda, ...
Cancer research 70 (18), 7155-7165
A role for BRCA1 in uterine leiomyosarcoma
D Xing, G Scangas, M Nitta, L He, X Xu, YJM Ioffe, PJ Aspuria, CY Hedvat, ...
Cancer research 69 (21), 8231-8235
ZIP8 Zinc Transporter: Indispensable Role for Both Multiple-Organ Organogenesis and Hematopoiesis In Utero
M Gálvez-Peralta, L He, LF Jorge-Nebert, B Wang, ML Miller, BL Eppert, ...
PloS one 7 (5), e36055
Generation of a Slc39a8 hypomorph mouse: Markedly decreased ZIP8 Zn 2+/transporter expression
B Wang, L He, H Dong, TP Dalton, DW Nebert
Biochemical and Biophysical Research Communications 410 (2), 289-294
Retrovirally expressed metal response element-binding transcription factor-1 normalizes metallothionein-1 gene expression and protects cells against zinc, but not cadmium, toxicity
WA Solis, NL Childs, MN Weedon, L He, DW Nebert, TP Dalton
Toxicology and applied pharmacology 178 (2), 93-101
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discov. 2012; 15: 1036–1047. doi: 10.1158/2159-8290
YH Ibrahim, C García-García, V Serra, L He, K Torres-Lockhart, A Prat, ...
CD-11-0348.[PubMed][Cross Ref]
ZIP14 and ZIP8 zinc/bicarbonate symporters in Xenopus oocytes: characterization of metal uptake and inhibition
DW Nebert, M Gálvez-Peralta, EB Hay, H Li, E Johansson, C Yin, B Wang, ...
Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma
L He, K Torres-Lockhart, N Forster, S Ramakrishnan, P Greninger, ...
Cancer Discovery
Identification of LMX1B as a novel oncogene in human ovarian cancer
L He, L Guo, V Vathipadiekal, PA Sergent, WB Growdon, DA Engler, ...
Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009.
SJ Isakoff, L He, EL Mayer, PE Goss, TA Traina, LA Carey, K Krag, MC Liu, ...
ASCO Annual Meeting Proceedings 32 (15_suppl), 1020
Abstract C102: Identify novel pathways conferring PARP inhibitor resistance in BRCA-associated breast and ovarian cancer.
L He, L Chen, S Ramakrishnan, K Torres-Lockhart, L Ellisen
Molecular Cancer Therapeutics 12 (11 Supplement), C102-C102
Show: 1-20Next >
Dates and citation counts are estimated and are determined automatically by a computer program.
©2013 Google - About Google Scholar - All About Google - Provide feedback - My Citations